Protagenic Therapeutics Inc. (PTIX)

[10452km2]

“The acquisition of Adenyo will further expand Motricity’s market reach and provide new revenue streams as we add agency and enterprise customers,” said James Ryan, chief strategy and marketing officer at Motricity, Bellevue, WA. “The acquisition will build Motricity’s existing technology platform and increase the company’s capabilities specifically in the areas of mobile marketing, mobile advertising and analytics.



“Simply put, on a day-to-day basis it won’t affect our customers,” he said. “What it will do is provide our combined customer base with the ability to fully leverage the mobile Internet as the landscape changes and as customers look to effectively market to their unique customer base.

“We are acquiring Adenyo for their technology, extensive customer relationships and professional expertise – the newly integrated team will continue to focus on growing the business as a whole, while adding mobile marketing, advertising and analytics to Motricity’s current platform.